Literature DB >> 19796426

Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11.

P Sachdev1, G Andrews, M J Hobbs, M Sunderland, T M Anderson.   

Abstract

BACKGROUND: In an effort to group mental disorders on the basis of aetiology, five clusters have been proposed. In this paper, we consider the validity of the first cluster, neurocognitive disorders, within this proposal. These disorders are categorized as 'Dementia, Delirium, and Amnestic and Other Cognitive Disorders' in DSM-IV and 'Organic, including Symptomatic Mental Disorders' in ICD-10.
METHOD: We reviewed the literature in relation to 11 validating criteria proposed by a Study Group of the DSM-V Task Force as applied to the cluster of neurocognitive disorders.
RESULTS: 'Neurocognitive' replaces the previous terms 'cognitive' and 'organic' used in DSM-IV and ICD-10 respectively as the descriptor for disorders in this cluster. Although cognitive/organic problems are present in other disorders, this cluster distinguishes itself by the demonstrable neural substrate abnormalities and the salience of cognitive symptoms and deficits. Shared biomarkers, co-morbidity and course offer less persuasive evidence for a valid cluster of neurocognitive disorders. The occurrence of these disorders subsequent to normal brain development sets this cluster apart from neurodevelopmental disorders. The aetiology of the disorders is varied, but the neurobiological underpinnings are better understood than for mental disorders in any other cluster.
CONCLUSIONS: Neurocognitive disorders meet some of the salient criteria proposed by the Study Group of the DSM-V Task Force to suggest a classification cluster. Further developments in the aetiopathogenesis of these disorders will enhance the clinical utility of this cluster.

Entities:  

Mesh:

Year:  2009        PMID: 19796426     DOI: 10.1017/S0033291709990262

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  8 in total

Review 1.  DSM-5 and Mental Disorders in Older Individuals: An Overview.

Authors:  Perminder S Sachdev; Adith Mohan; Lauren Taylor; Dilip V Jeste
Journal:  Harv Rev Psychiatry       Date:  2015 Sep-Oct       Impact factor: 3.732

Review 2.  Management of delirium in palliative care: a review.

Authors:  Luigi Grassi; Augusto Caraceni; Alex J Mitchell; Maria Giulia Nanni; Maria Alejandra Berardi; Rosangela Caruso; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2015-03       Impact factor: 5.285

3.  The DSM-5: Classification and criteria changes.

Authors:  Darrel A Regier; Emily A Kuhl; David J Kupfer
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

4.  The predictive validity of the 10/66 dementia diagnosis in Chennai, India: a 3-year follow-up study of cases identified at baseline.

Authors:  A T Jotheeswaran; Joseph D Williams; Martin J Prince
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

Review 5.  Classifying neurocognitive disorders: the DSM-5 approach.

Authors:  Perminder S Sachdev; Deborah Blacker; Dan G Blazer; Mary Ganguli; Dilip V Jeste; Jane S Paulsen; Ronald C Petersen
Journal:  Nat Rev Neurol       Date:  2014-09-30       Impact factor: 42.937

6.  Patterns of comorbidity among mental disorders: a person-centered approach.

Authors:  Uma Vaidyanathan; Christopher J Patrick; William G Iacono
Journal:  Compr Psychiatry       Date:  2010-12-15       Impact factor: 3.735

Review 7.  Neurodevelopmental disorders: cluster 2 of the proposed meta-structure for DSM-V and ICD-11.

Authors:  G Andrews; D S Pine; M J Hobbs; T M Anderson; M Sunderland
Journal:  Psychol Med       Date:  2009-10-01       Impact factor: 7.723

8.  Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults.

Authors:  Ranmalee Eramudugolla; Moyra E Mortby; Perminder Sachdev; Chantal Meslin; Rajeev Kumar; Kaarin J Anstey
Journal:  Alzheimers Res Ther       Date:  2017-03-04       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.